Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis

Blood

Volumn 99, Issue 7, 2002, Pages 2612-2614

  Viallard, Jean François ^a,b   Solanilla, Anne ^a,b   Gauthier, Bruno ^a,b   Contin, Cécile ^a,b   Déchanet, Julie ^a,b   Grosset, Christophe ^a,b   Moreau, Jean François ^a,b   Praloran, Vincent ^a,b   Nurden, Paquita ^a,b   Pellegrin, Jean Luc ^a,b   Nurden, Alan T ^a,b   Ripoche, Jean ^a,b  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOCYTOSIS;

EID: 0036529828     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.7.2612     Document Type: Article

References (14)

1. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation
2. Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells
3. The soluble CD40 ligand sCD154 in systemic lupus erythematosus
4. Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera
5. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes
6. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
7. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: A final report on diagnostic criteria, survival, and leukemic transition by treatment
8. Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: A study using Ca2+-ATPase inhibitors
9. Distribution of ligand-occupied α lib β 3 in resting and activated human platelets determined by expression of a novel class of ligand-induced binding site recognized by monodonal antibody AP6
10. PAICA: A new method for characterizing plateletassociated antibodies - Its application to study of idiopathic thrombocytopenic purpura and to the detection of platelet-bound c7E3
11. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes
12. Platelet CD40 ligand (CD40L) subcellular localization, regulation of expression, and inhibition by clopidogrel
13. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40
14. Defects in arterial thrombus formation in CD40L-/mice